PubMed چکیده/رکورد

Cyanidin-3-glucoside mitigates zearalenone-enhanced hepatic lipotoxicity via inhibition of PXR activation.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Zearalenone (ZEA) is a mycotoxin frequently detected in food. Cyanidin-3-glucoside (C3G), an anthocyanin abundant in food, exhibits regulatory effects on hepatic metabolism; however, its role in ZEA-induced hepatic lipotoxicity remains unclear. In this study, C57BL/6 J mice were exposed to low-dose ZEA (0.5 mg/kg·bw) combined with a combined with a high-fat diet (HFD) for 96 days, and HepG2 and HepaRG cells were treated with ZEA and oleic acid to investigate chronic ZEA-induced metabolic disturbances. C3G was administered to evaluate its protective effects. ZEA disrupted hepatic energy metabolism, promoted lipid accumulation, and induced more severe lipotoxicity. Mechanistically, ZEA activated the pregnane X receptor (PXR), upregulating fatty acid transporters CD36 and FABP4, thereby enhancing fatty acid uptake and lipid synthesis. C3G inhibits ZEA-induced PXR activation, thereby suppressing PXR signaling and alleviating ZEA-induced hepatic lipotoxicity under HFD conditions. Collectively, C3G mitigates ZEA-induced hepatic lipotoxicity by inhibiting PXR activation, highlighting anthocyanins as potential interventions against mycotoxin-associated metabolic injury.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

AnthocyaninsCyanidin-3-O-glucosideMetabolic associated fatty liver diseasePregnane X receptorZearalenone
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Intestinal gases as markers to study the diet-gut microbiota-host metabolism axis in humans and their relationship to metabolic health.

The gut microbiota‒host metabolism axis is a critical determinant of metabolic health, yet its functional activity remains difficult to monitor in vivo. The gut microbiota ferments undigested food components such as dietary fibers and proteins, yielding various important metabolites and gases that impact human metabolism. This review synthesizes current evidence on intestinal gases, primarily hydrogen (H2), methane (CH4) and hydrogen s…

PubMed2026

The onset of hypertension in metabolic syndrome is independent of renal sympathetic innervation.

Increased sympathetic tone and hypertension are hallmarks of metabolic syndrome and contribute to chronic kidney disease. Although renal sympathetic denervation transiently lowers blood pressure, its role in the development of metabolic and renal alterations remains unclear. Here, we evaluated the contribution of renal sympathetic input to the onset and progression of high-fat diet-induced alterations. Male Wistar rats underwent bilate…

PubMed2026

Lactiplantibacillus plantarum WJL ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein diet.

Low-protein diets (LPD) are recommended in chronic kidney disease (CKD) to reduce disease progression. However, their clinical efficacy and safety are debated due to the risk of protein-energy wasting. A deeper mechanistic understanding is therefore required. Herein, the metabolic effects of LPD in both murine models and a randomized controlled trial in nondiabetic CKD patients were investigated, focusing on glucose homeostasis, plasma…

PubMed2026

Christensenella massiliensis reduces kynurenine levels and alleviates obesity and related metabolic disorders in model mice.

Next-generation probiotics derived from gut commensals show promise for metabolic disease intervention, yet effective anti-obesity strains remain limited. Here, we demonstrate that oral administration of Christensenella massiliensis markedly alleviates obesity and metabolic dysfunction in high-fat diet-induced obese mice. Treatment reduced food intake, improved glucose tolerance and insulin sensitivity, lowered blood glucose and lipid …